REIT - Residential
Compare Stocks
5 / 10Stock Comparison
VRE vs UDR vs CPT vs EQR vs ESS
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Residential
REIT - Residential
REIT - Residential
REIT - Residential
VRE vs UDR vs CPT vs EQR vs ESS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Residential | REIT - Residential | REIT - Residential | REIT - Residential | REIT - Residential |
| Market Cap | $1.78B | $12.04B | $10.97B | $24.82B | $17.20B |
| Revenue (TTM) | $291M | $1.72B | $1.18B | $3.12B | $1.91B |
| Net Income (TTM) | $70M | $491M | $388M | $954M | $576M |
| Gross Margin | 23.4% | 46.0% | 61.3% | 46.3% | 69.4% |
| Operating Margin | 14.7% | 27.4% | 18.1% | 28.5% | 38.4% |
| Forward P/E | 23.7x | 66.2x | 68.4x | 50.8x | 46.6x |
| Total Debt | $1.37B | $6.19B | $3.90B | $8.78B | $6.90B |
| Cash & Equiv. | $14M | $37M | $25M | $56M | $86M |
VRE vs UDR vs CPT vs EQR vs ESS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Veris Residential, … (VRE) | 100 | 124.6 | +24.6% |
| UDR, Inc. (UDR) | 100 | 100.2 | +0.2% |
| Camden Property Tru… (CPT) | 100 | 114.5 | +14.5% |
| Equity Residential (EQR) | 100 | 109.2 | +9.2% |
| Essex Property Trus… (ESS) | 100 | 110.1 | +10.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VRE vs UDR vs CPT vs EQR vs ESS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VRE carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 6.4%, EPS growth 420.0%, 3Y rev CAGR 7.3%
- Lower volatility, beta 0.22, current ratio 0.08x
- Lower P/E (23.7x vs 50.8x)
- Beta 0.22 vs ESS's 0.43, lower leverage
UDR is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 15 yrs, beta 0.39, yield 4.6%
- PEG 1.60 vs ESS's 12.60
- Beta 0.39, yield 4.6%, current ratio 3.31x
- 4.6% yield, 15-year raise streak, vs CPT's 4.1%
CPT ranks third and is worth considering specifically for quality.
- 32.8% margin vs VRE's 24.2%
Among these 5 stocks, EQR doesn't own a clear edge in any measured category.
ESS is the clearest fit if your priority is long-term compounding.
- 53.4% 10Y total return vs CPT's 71.7%
- 7.1% FFO/revenue growth vs CPT's 1.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.1% FFO/revenue growth vs CPT's 1.9% | |
| Value | Lower P/E (23.7x vs 50.8x) | |
| Quality / Margins | 32.8% margin vs VRE's 24.2% | |
| Stability / Safety | Beta 0.22 vs ESS's 0.43, lower leverage | |
| Dividends | 4.6% yield, 15-year raise streak, vs CPT's 4.1% | |
| Momentum (1Y) | +21.1% vs UDR's -10.1% | |
| Efficiency (ROA) | 4.7% ROA vs VRE's 2.5%, ROIC 2.3% vs 1.3% |
VRE vs UDR vs CPT vs EQR vs ESS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
VRE vs UDR vs CPT vs EQR vs ESS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
VRE leads in 2 of 6 categories
UDR leads 1 • CPT leads 0 • EQR leads 0 • ESS leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — CPT and ESS each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EQR is the larger business by revenue, generating $3.1B annually — 10.7x VRE's $291M. CPT is the more profitable business, keeping 32.8% of every revenue dollar as net income compared to VRE's 24.2%. On growth, VRE holds the edge at +3.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $291M | $1.7B | $1.2B | $3.1B | $1.9B |
| EBITDAEarnings before interest/tax | $129M | $1.1B | $867M | $1.9B | $1.3B |
| Net IncomeAfter-tax profit | $70M | $491M | $388M | $954M | $576M |
| Free Cash FlowCash after capex | $50M | $892M | $714M | $1.3B | $962M |
| Gross MarginGross profit ÷ Revenue | +23.4% | +46.0% | +61.3% | +46.3% | +69.4% |
| Operating MarginEBIT ÷ Revenue | +14.7% | +27.4% | +18.1% | +28.5% | +38.4% |
| Net MarginNet income ÷ Revenue | +24.2% | +28.6% | +32.8% | +30.6% | +30.2% |
| FCF MarginFCF ÷ Revenue | +17.1% | +52.0% | +60.4% | +42.7% | +50.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.5% | +0.9% | -100.0% | +2.5% | +1.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -36.4% | +147.8% | +11.1% | -64.2% | -47.8% |
Valuation Metrics
Evenly matched — VRE and EQR and ESS each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 22.8x trailing earnings, EQR trades at a 30% valuation discount to UDR's 32.7x P/E. Adjusting for growth (PEG ratio), UDR offers better value at 0.79x vs ESS's 6.92x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.8B | $12.0B | $11.0B | $24.8B | $17.2B |
| Enterprise ValueMkt cap + debt − cash | $3.1B | $18.2B | $14.8B | $33.6B | $24.0B |
| Trailing P/EPrice ÷ TTM EPS | 23.68x | 32.69x | 29.59x | 22.77x | 25.62x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 66.24x | 68.43x | 50.84x | 46.64x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.79x | 1.27x | 4.47x | 6.92x |
| EV / EBITDAEnterprise value multiple | 23.07x | 18.15x | 16.50x | 15.68x | 16.66x |
| Price / SalesMarket cap ÷ Revenue | 6.16x | 7.03x | 6.97x | 8.00x | 9.05x |
| Price / BookPrice ÷ Book value/share | 1.52x | 2.95x | 2.56x | 2.26x | 3.00x |
| Price / FCFMarket cap ÷ FCF | 32.34x | 19.61x | 28.40x | 19.25x | 16.00x |
Profitability & Efficiency
Evenly matched — VRE and UDR each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
UDR delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $6 for VRE. EQR carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to UDR's 1.49x. On the Piotroski fundamental quality scale (0–9), VRE scores 7/9 vs ESS's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.6% | +12.4% | +8.7% | +8.4% | +10.0% |
| ROA (TTM)Return on assets | +2.5% | +4.7% | +4.3% | +4.6% | +4.4% |
| ROICReturn on invested capital | +1.3% | +2.3% | +2.6% | +4.2% | +5.0% |
| ROCEReturn on capital employed | +2.0% | +3.1% | +3.4% | +5.7% | +6.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 7 | 6 | 6 |
| Debt / EquityFinancial leverage | 1.07x | 1.49x | 0.88x | 0.77x | 1.20x |
| Net DebtTotal debt minus cash | $1.4B | $6.2B | $3.9B | $8.7B | $6.8B |
| Cash & Equiv.Liquid assets | $14M | $37M | $25M | $56M | $86M |
| Total DebtShort + long-term debt | $1.4B | $6.2B | $3.9B | $8.8B | $6.9B |
| Interest CoverageEBIT ÷ Interest expense | 1.84x | — | 3.89x | 5.58x | 3.71x |
Total Returns (Dividends Reinvested)
VRE leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in VRE five years ago would be worth $11,971 today (with dividends reinvested), compared to $10,016 for UDR. Over the past 12 months, VRE leads with a +21.1% total return vs UDR's -10.1%. The 3-year compound annual growth rate (CAGR) favors ESS at 10.4% vs UDR's 0.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +28.2% | +3.0% | -4.0% | +9.1% | +5.8% |
| 1-Year ReturnPast 12 months | +21.1% | -10.1% | -8.6% | -2.5% | -3.9% |
| 3-Year ReturnCumulative with dividends | +20.6% | +1.8% | +6.1% | +17.4% | +34.7% |
| 5-Year ReturnCumulative with dividends | +19.7% | +0.2% | +5.4% | +10.4% | +11.7% |
| 10-Year ReturnCumulative with dividends | -11.9% | +41.5% | +71.7% | +32.0% | +53.4% |
| CAGR (3Y)Annualised 3-year return | +6.4% | +0.6% | +2.0% | +5.5% | +10.4% |
Risk & Volatility
VRE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
VRE is the less volatile stock with a 0.22 beta — it tends to amplify market swings less than ESS's 0.43 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VRE currently trades 99.5% from its 52-week high vs UDR's 84.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.22x | 0.39x | 0.36x | 0.38x | 0.43x |
| 52-Week HighHighest price in past year | $19.03 | $43.62 | $121.33 | $71.80 | $294.09 |
| 52-Week LowLowest price in past year | $13.69 | $32.94 | $96.53 | $57.58 | $238.47 |
| % of 52W HighCurrent price vs 52-week peak | +99.5% | +84.7% | +86.3% | +92.3% | +90.7% |
| RSI (14)Momentum oscillator 0–100 | 67.3 | 59.9 | 55.9 | 66.9 | 63.6 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 3.2M | 986K | 2.3M | 435K |
Analyst Outlook
UDR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VRE as "Hold", UDR as "Buy", CPT as "Hold", EQR as "Hold", ESS as "Hold". Consensus price targets imply 9.0% upside for UDR (target: $40) vs -26.1% for VRE (target: $14). For income investors, UDR offers the higher dividend yield at 4.64% vs VRE's 1.70%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $14.00 | $40.25 | $112.48 | $70.15 | $279.20 |
| # AnalystsCovering analysts | 12 | 38 | 41 | 46 | 46 |
| Dividend YieldAnnual dividend ÷ price | +1.7% | +4.6% | +4.1% | +4.1% | +3.8% |
| Dividend StreakConsecutive years of raises | 3 | 15 | 4 | 8 | 11 |
| Dividend / ShareAnnual DPS | $0.32 | $1.72 | $4.25 | $2.69 | $10.15 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | +1.0% | +2.5% | +1.1% | +0.0% |
VRE leads in 2 of 6 categories (Total Returns, Risk & Volatility). UDR leads in 1 (Analyst Outlook). 3 tied.
VRE vs UDR vs CPT vs EQR vs ESS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VRE or UDR or CPT or EQR or ESS a better buy right now?
For growth investors, Essex Property Trust, Inc.
(ESS) is the stronger pick with 7. 1% revenue growth year-over-year, versus 1. 9% for Camden Property Trust (CPT). Equity Residential (EQR) offers the better valuation at 22. 8x trailing P/E (50. 8x forward), making it the more compelling value choice. Analysts rate UDR, Inc. (UDR) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VRE or UDR or CPT or EQR or ESS?
On trailing P/E, Equity Residential (EQR) is the cheapest at 22.
8x versus UDR, Inc. at 32. 7x. On forward P/E, Essex Property Trust, Inc. is actually cheaper at 46. 6x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: UDR, Inc. wins at 1. 60x versus Essex Property Trust, Inc. 's 12. 60x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — VRE or UDR or CPT or EQR or ESS?
Over the past 5 years, Veris Residential, Inc.
(VRE) delivered a total return of +19. 7%, compared to +0. 2% for UDR, Inc. (UDR). Over 10 years, the gap is even starker: CPT returned +68. 5% versus VRE's -12. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VRE or UDR or CPT or EQR or ESS?
By beta (market sensitivity over 5 years), Veris Residential, Inc.
(VRE) is the lower-risk stock at 0. 22β versus Essex Property Trust, Inc. 's 0. 43β — meaning ESS is approximately 94% more volatile than VRE relative to the S&P 500. On balance sheet safety, Equity Residential (EQR) carries a lower debt/equity ratio of 77% versus 149% for UDR, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VRE or UDR or CPT or EQR or ESS?
By revenue growth (latest reported year), Essex Property Trust, Inc.
(ESS) is pulling ahead at 7. 1% versus 1. 9% for Camden Property Trust (CPT). On earnings-per-share growth, the picture is similar: Veris Residential, Inc. grew EPS 420. 0% year-over-year, compared to -9. 8% for Essex Property Trust, Inc.. Over a 3-year CAGR, VRE leads at 7. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VRE or UDR or CPT or EQR or ESS?
Equity Residential (EQR) is the more profitable company, earning 36.
1% net margin versus 22. 1% for UDR, Inc. — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ESS leads at 43. 9% versus 17. 1% for VRE. At the gross margin level — before operating expenses — ESS leads at 68. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VRE or UDR or CPT or EQR or ESS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, UDR, Inc. (UDR) is the more undervalued stock at a PEG of 1. 60x versus Essex Property Trust, Inc. 's 12. 60x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Essex Property Trust, Inc. (ESS) trades at 46. 6x forward P/E versus 68. 4x for Camden Property Trust — 21. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UDR: 9. 0% to $40. 25.
08Which pays a better dividend — VRE or UDR or CPT or EQR or ESS?
All stocks in this comparison pay dividends.
UDR, Inc. (UDR) offers the highest yield at 4. 6%, versus 1. 7% for Veris Residential, Inc. (VRE).
09Is VRE or UDR or CPT or EQR or ESS better for a retirement portfolio?
For long-horizon retirement investors, Veris Residential, Inc.
(VRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 22), 1. 7% yield). Both have compounded well over 10 years (VRE: -12. 8%, ESS: +51. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VRE and UDR and CPT and EQR and ESS?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: VRE is a small-cap quality compounder stock; UDR is a mid-cap income-oriented stock; CPT is a mid-cap income-oriented stock; EQR is a mid-cap income-oriented stock; ESS is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.